The Food and Drug Administration said several lots of six products containing benzoyl peroxide are being recalled, including ...

Roche has acquired rights to an obesity therapy by Denmark's Zealand Pharma in a collaboration deal worth up to $5.3 billion, ...

The deal gives the Swiss pharma access to an experimental amylin-targeting treatment it will test in combination with drugs ...

The FDA tested 95 products containing benzoyl peroxide, an ingredient widely used to treat acne that can form benzene as a byproduct. It found that six products could have more benzene than usual.

Roche partnered with Zealand Pharma to license an experimental weight loss drug for $1.65 billion upfront, expanding its ...

That’s also the timeline for starting a separate mid-stage test enrolling patients with obesity or overweight with type 2 diabetes. Roche entered the obesity drug chase with its $2.3 billion ...

"FDA is alerting the public and industry to the results of new agency testing of 95 acne products ... in these lots," the statement read. La Roche-Posay, which is owned by L'Oreal, and Walgreens ...

F. Hoffmann-La Roche, one of the world’s largest biotechnology companies, announced on Thursday that it will establish an ...

Roche said the approach could one day be suitable for whole genome and exome sequencing as well as parsing RNA, offering applications in research labs and potentially clinical testing. The company ...

The companies will now work together to develop petrelintide, aiming to test it on its own and in combination with Roche’s experimental CT-388. Petrelintide is a once-weekly injection that is ...